Opioids Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Immediate-Release Short-Acting Opioids and Extended-Release Long-Acting Opioid), Application (Pain Management, Anaesthesia, Diarrhoea Suppression, Cough Suppression, De-Addiction, and Others), Route Of Administration (Oral, Injectable, and Transdermal Patch), Distribution Channel (Hospital Pharmacies and Retail Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
The Opioids market is expected to grow from US$ 12.93 billion in 2023 to US$ 15.03 billion by 2031; it is anticipated to record a CAGR of 1.9% from 2023 to 2031.
Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.
Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.
Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.
Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023–2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI’s commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium’s portfolio of pain products. Thus, the factors mentioned above support the market growth.
Opioids are a broad group of medicines majorly used for relieving pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances. The growing opioids market size is attributed to the surging chronic pain incidences across the world. In addition, the increasing geriatric population across the world are fueling opioid market growth. A government initiative focusing on the development of medication to prevent and treat opioid overdose and disorders is likely to bring new opioids market trends during the forecast period.
Strategic Initiatives by Market Players will Create an Opportunity for Opioid market growth.
Opioids market players invest in R&D activities to ensure the development of effective products. In May 2023, Indivior PLC received the US Food and Drug Administration (FDA) approval for OPVEE (nalmefene) nasal spray for emergency use to treat suspected or known opioid overdose induced by synthetic or natural opioids in adults and pediatric patients aged 12 years and more, which is characterized by CNS and/or respiratory depression. Further, in December 2021, Sandoz announced the launch of its generic Narcan (naloxone hydrochloride) Nasal Spray 4mg in the US; the product is used to reverse opioid overdose. Individuals in the US can immediately obtain Narcan via retail pharmacies and institutions, including hospitals. Lastly, in August 2023, Emergent BioSolutions launched the over-the-counter NARCAN Nasal Spray, making it possible for everybody to help save a life from an opioid overdose emergency. Therefore, strategic initiatives are likely to offer growth opportunities to the opioids market in the coming years.
Based on geography, the Opioid market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, Southeast Asia, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America). North America held the largest share of the global Opioid market in 2023 owing to the lifestyle factor. However, Asia Pacific is predicted to register the highest CAGR during 2023–2031. The US held the largest share of the Opioid market in North America in 2022. US market players are adopting organic and inorganic strategies for Opioid market development. For instance, in 2024, Hikma Pharmaceuticals PLC launched Fentanyl Citrate Injection, USP, in 25mcg/0.5mL and 50mcg/mL doses. Hikma introduced the first FDA approved 25mcg/0.5mL presentation to the US market. The company is expected to expand its portfolio with the launch, broadening the choice of medicines available to hospitals. Furthermore, in 2023, Rusan Pharma launched its state-of-the-art API facility in Madhya Pradesh, India. The facility is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance. With the production capability of 400 metric tons of APIs annually. This facility expansion will ensure the security of supply of critical APIs to meet the growing demand for addiction treatment and pain management products in India and globally. Moreover in 2023, Neuraxpharm announced the closing of the acquisition of two established product portfolios for CNS disorders, pain and vascular diseases from Sanofi. The well-established products that Neuraxpharm acquired includes 15 products addressing CNS disorders and two products in pain and vascular diseases, and in 2022, Collegium Pharmaceutical, Inc. announced that it completed the acquisition of BioDelivery Sciences International Inc. BDSI has a portfolio of pain and neurology products that address serious and debilitating conditions. BDSI’s commercial growth driver, BELBUCA, is a meaningfully differentiated schedule III opioid product and is highly complementary to Collegium’s portfolio of pain products. Thus, the factors mentioned above support the market growth.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. OPIOIDS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. OPIOIDS MARKET – KEY MARKET DYNAMICS
5.1 Opioids Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
6. OPIOIDS MARKET – GLOBAL MARKET ANALYSIS
6.1 Opioids Market Revenue (US$ Million), 2022–2030
6.2 Opioids Market Forecast Analysis
7. OPIOIDS MARKET ANALYSIS – BY PRODUCT
7.1 Immediate Release Short Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
8. OPIOIDS MARKET ANALYSIS – BY APPLICATION
8.1 Pain Management
8.1.1 Overview
8.1.2 Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9. OPIOIDS MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10. OPIOIDS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11. OPIOIDS MARKET – GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market – Revenue and Forecast Analysis – by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market – Revenue and Forecast Analysis – by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.2.4.2 North America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.5 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.1 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.2 United States: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Product
11.3.3.2 Europe: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Application
11.3.3.5 Europe: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.3.3.6 Europe: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.2 United Kingdom: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Product
11.4.2.2 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Application
11.4.2.5 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.2 China: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Product
11.5.2.2 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Application
11.5.2.5 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Country
11.5.2.8 Saudi Arabia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Product
11.6.2.2 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Application
11.6.2.5 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Route Of Administration
11.6.2.6 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.6.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.2 Brazil: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Purdue Pharma LP
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. OPIOIDS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. OPIOIDS MARKET – KEY MARKET DYNAMICS
5.1 Opioids Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Surging Chronic Pain Incidence
5.2.2 Increasing Geriatric Population
5.3 Market Restraints
5.3.1 Increasing Drug Abuse
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
5.5.1 Government Initiatives Focusing on Development of Medication to Prevent and Treat Opioid Overdose and Disorder
5.6 Impact of Drivers and Restraints:
6. OPIOIDS MARKET – GLOBAL MARKET ANALYSIS
6.1 Opioids Market Revenue (US$ Million), 2022–2030
6.2 Opioids Market Forecast Analysis
7. OPIOIDS MARKET ANALYSIS – BY PRODUCT
7.1 Immediate Release Short Acting Opioid
7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Immediate Release Short Acting Opioid
7.2 Extended Release Long-Acting Opioid
7.2.1 Overview
7.2.2 Extended Release Long-Acting Opioid: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Global Opioids Market – Revenue and Forecast to 2030 (US$ Million) – by Extended Release Long-Acting Opioid
8. OPIOIDS MARKET ANALYSIS – BY APPLICATION
8.1 Pain Management
8.1.1 Overview
8.1.2 Pain Management: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Anesthesia
8.2.1 Overview
8.2.2 Anesthesia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Diarrhoea Suppression
8.3.1 Overview
8.3.2 Diarrhoea Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cough Suppression
8.4.1 Overview
8.4.2 Cough Suppression: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.5 De-Addiction
8.5.1 Overview
8.5.2 De-Addiction: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9. OPIOIDS MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Oral
9.1.1 Overview
9.1.2 Oral: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Injectable
9.2.1 Overview
9.2.2 Injectable: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Transdermal Patch
9.3.1 Overview
9.3.2 Transdermal Patch: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10. OPIOIDS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
10.1 Hospital Pharmacies
10.1.1 Overview
10.1.2 Hospital Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Retail Pharmacies: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11. OPIOIDS MARKET – GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Opioids Market Overview
11.2.2 North America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 North America: Opioids Market – Revenue and Forecast Analysis – by Product
11.2.3 North America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.3.1 North America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.2.3.2 North America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.2.3.3 North America: Opioids Market – Revenue and Forecast Analysis – by Application
11.2.4 North America: Opioids Market Breakdown, by Route of Administration
11.2.4.1 North America: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.2.4.2 North America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.5 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.1 North America: Opioids Market – Revenue and Forecast Analysis – by Country
11.2.5.2 United States: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.2.1 United States: Opioids Market Breakdown, by Product
11.2.5.2.2 United States: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.2.3 United States: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.2.4 United States: Opioids Market Breakdown, by Application
11.2.5.2.5 United States: Opioids Market Breakdown, by Route of Administration
11.2.5.2.6 United States: Opioids Market Breakdown, by Distribution Channel
11.2.5.3 Canada: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.3.1 Canada: Opioids Market Breakdown, by Product
11.2.5.3.2 Canada: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.3.3 Canada: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.3.4 Canada: Opioids Market Breakdown, by Application
11.2.5.3.5 Canada: Opioids Market Breakdown, by Route of Administration
11.2.5.3.6 Canada: Opioids Market Breakdown, by Distribution Channel
11.2.5.4 Mexico: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.2.5.4.1 Mexico: Opioids Market Breakdown, by Product
11.2.5.4.2 Mexico: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.2.5.4.3 Mexico: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.2.5.4.4 Mexico: Opioids Market Breakdown, by Application
11.2.5.4.5 Mexico: Opioids Market Breakdown, by Route of Administration
11.2.5.4.6 Mexico: Opioids Market Breakdown, by Distribution Channel
11.3 Europe
11.3.1 Europe Opioids Market Overview
11.3.2 Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Europe: Opioids Market Breakdown, by Product
11.3.3.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Product
11.3.3.2 Europe: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.3.3.3 Europe: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.3.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Application
11.3.3.5 Europe: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.3.3.6 Europe: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.4 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.1 Europe: Opioids Market – Revenue and Forecast Analysis – by Country
11.3.4.2 United Kingdom: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.2.1 United Kingdom: Opioids Market Breakdown, by Product
11.3.4.2.2 United Kingdom: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.2.3 United Kingdom: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.2.4 United Kingdom: Opioids Market Breakdown, by Application
11.3.4.2.5 United Kingdom: Opioids Market Breakdown, by Route of Administration
11.3.4.2.6 United Kingdom: Opioids Market Breakdown, by Distribution Channel
11.3.4.3 Germany: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.3.1 Germany: Opioids Market Breakdown, by Product
11.3.4.3.2 Germany: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.3.3 Germany: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.3.4 Germany: Opioids Market Breakdown, by Application
11.3.4.3.5 Germany: Opioids Market Breakdown, by Route of Administration
11.3.4.3.6 Germany: Opioids Market Breakdown, by Distribution Channel
11.3.4.4 France: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.4.1 France: Opioids Market Breakdown, by Product
11.3.4.4.2 France: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.4.3 France: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.4.4 France: Opioids Market Breakdown, by Application
11.3.4.4.5 France: Opioids Market Breakdown, by Route of Administration
11.3.4.4.6 France: Opioids Market Breakdown, by Distribution Channel
11.3.4.5 Italy: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.5.1 Italy: Opioids Market Breakdown, by Product
11.3.4.5.2 Italy: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.5.3 Italy: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.5.4 Italy: Opioids Market Breakdown, by Application
11.3.4.5.5 Italy: Opioids Market Breakdown, by Route of Administration
11.3.4.5.6 Italy: Opioids Market Breakdown, by Distribution Channel
11.3.4.6 Spain: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.6.1 Spain: Opioids Market Breakdown, by Product
11.3.4.6.2 Spain: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.6.3 Spain: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.6.4 Spain: Opioids Market Breakdown, by Application
11.3.4.6.5 Spain: Opioids Market Breakdown, by Route of Administration
11.3.4.6.6 Spain: Opioids Market Breakdown, by Distribution Channel
11.3.4.7 Rest of Europe: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.3.4.7.1 Rest of Europe: Opioids Market Breakdown, by Product
11.3.4.7.2 Rest of Europe: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.3.4.7.3 Rest of Europe: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.3.4.7.4 Rest of Europe: Opioids Market Breakdown, by Application
11.3.4.7.5 Rest of Europe: Opioids Market Breakdown, by Route of Administration
11.3.4.7.6 Rest of Europe: Opioids Market Breakdown, by Distribution Channel
11.4 Asia Pacific
11.4.1 Asia Pacific Opioids Market Overview
11.4.2 Asia Pacific: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Product
11.4.2.2 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.4.2.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.4.2.4 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Application
11.4.2.5 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.6 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Asia Pacific: Opioids Market – Revenue and Forecast Analysis – by Country
11.4.3.2 China: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 China: Opioids Market Breakdown, by Product
11.4.3.2.2 China: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.2.3 China: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.2.4 China: Opioids Market Breakdown, by Application
11.4.3.2.5 China: Opioids Market Breakdown, by Route of Administration
11.4.3.2.6 China: Opioids Market Breakdown, by Distribution Channel
11.4.3.3 Japan: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Japan: Opioids Market Breakdown, by Product
11.4.3.3.2 Japan: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.3.3 Japan: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.3.4 Japan: Opioids Market Breakdown, by Application
11.4.3.3.5 Japan: Opioids Market Breakdown, by Route of Administration
11.4.3.3.6 Japan: Opioids Market Breakdown, by Distribution Channel
11.4.3.4 India: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 India: Opioids Market Breakdown, by Product
11.4.3.4.2 India: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.4.3 India: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.4.4 India: Opioids Market Breakdown, by Application
11.4.3.4.5 India: Opioids Market Breakdown, by Route of Administration
11.4.3.4.6 India: Opioids Market Breakdown, by Distribution Channel
11.4.3.5 South Korea: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Korea: Opioids Market Breakdown, by Product
11.4.3.5.2 South Korea: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.5.3 South Korea: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.5.4 South Korea: Opioids Market Breakdown, by Application
11.4.3.5.5 South Korea: Opioids Market Breakdown, by Route of Administration
11.4.3.5.6 South Korea: Opioids Market Breakdown, by Distribution Channel
11.4.3.6 Australia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Australia: Opioids Market Breakdown, by Product
11.4.3.6.2 Australia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.6.3 Australia: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.6.4 Australia: Opioids Market Breakdown, by Application
11.4.3.6.5 Australia: Opioids Market Breakdown, by Route of Administration
11.4.3.6.6 Australia: Opioids Market Breakdown, by Distribution Channel
11.4.3.7 Rest of APAC: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 Rest of APAC: Opioids Market Breakdown, by Product
11.4.3.7.2 Rest of APAC: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.4.3.7.3 Rest of APAC: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.4.3.7.4 Rest of APAC: Opioids Market Breakdown, by Application
11.4.3.7.5 Rest of APAC: Opioids Market Breakdown, by Route of Administration
11.4.3.7.6 Rest of APAC: Opioids Market Breakdown, by Distribution Channel
11.5 Middle East and Africa
11.5.1 Middle East and Africa Opioids Market Overview
11.5.2 Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Product
11.5.2.2 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.5.2.3 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long-Acting Opioid
11.5.2.4 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Application
11.5.2.5 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.6 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.2.7 Middle East and Africa: Opioids Market – Revenue and Forecast Analysis – by Country
11.5.2.8 Saudi Arabia: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.8.1 Saudi Arabia: Opioids Market Breakdown, by Product
11.5.2.8.2 Saudi Arabia: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.8.3 Saudi Arabia: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.8.4 Saudi Arabia: Opioids Market Breakdown, by Application
11.5.2.8.5 Saudi Arabia: Opioids Market Breakdown, by Route Of Administration
11.5.2.8.6 Saudi Arabia: Opioids Market Breakdown, by Distribution Channel
11.5.2.9 South Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.9.1 South Africa: Opioids Market Breakdown, by Product
11.5.2.9.2 South Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.9.3 South Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.9.4 South Africa: Opioids Market Breakdown, by Application
11.5.2.9.5 South Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.9.6 South Africa: Opioids Market Breakdown, by Distribution Channel
11.5.2.10 United Arab Emirates: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.10.1 United Arab Emirates: Opioids Market Breakdown, by Product
11.5.2.10.2 United Arab Emirates: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.10.3 United Arab Emirates: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.10.4 United Arab Emirates: Opioids Market Breakdown, by Application
11.5.2.10.5 United Arab Emirates: Opioids Market Breakdown, by Route Of Administration
11.5.2.10.6 United Arab Emirates: Opioids Market Breakdown, by Distribution Channel
11.5.2.11 Rest of Middle East and Africa: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.11.1 Rest of Middle East and Africa: Opioids Market Breakdown, by Product
11.5.2.11.2 Rest of Middle East and Africa: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.5.2.11.3 Rest of Middle East and Africa: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.5.2.11.4 Rest of Middle East and Africa: Opioids Market Breakdown, by Application
11.5.2.11.5 Rest of Middle East and Africa: Opioids Market Breakdown, by Route Of Administration
11.5.2.11.6 Rest of Middle East and Africa: Opioids Market Breakdown, by Distribution Channel
11.6 South and Central America
11.6.1 South and Central America Opioids Market Overview
11.6.2 South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.2.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Product
11.6.2.2 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Immediate Release Short Acting Opioid
11.6.2.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Extended Release Long Acting Opioid
11.6.2.4 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Application
11.6.2.5 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Route Of Administration
11.6.2.6 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Distribution Channel
11.6.3 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.1 South and Central America: Opioids Market – Revenue and Forecast Analysis – by Country
11.6.3.2 Brazil: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.2.1 Brazil: Opioids Market Breakdown, by Product
11.6.3.2.2 Brazil: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.2.3 Brazil: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.2.4 Brazil: Opioids Market Breakdown, by Application
11.6.3.2.5 Brazil: Opioids Market Breakdown, by Route Of Administration
11.6.3.2.6 Brazil: Opioids Market Breakdown, by Distribution Channel
11.6.3.3 Argentina: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.3.1 Argentina: Opioids Market Breakdown, by Product
11.6.3.3.2 Argentina: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.3.3 Argentina: Opioids Market Breakdown, by Extended Release Long-Acting Opioid
11.6.3.3.4 Argentina: Opioids Market Breakdown, by Application
11.6.3.3.5 Argentina: Opioids Market Breakdown, by Route Of Administration
11.6.3.3.6 Argentina: Opioids Market Breakdown, by Distribution Channel
11.6.3.4 Rest of South and Central America: Opioids Market – Revenue and Forecast to 2030 (US$ Million)
11.6.3.4.1 Rest of South and Central America: Opioids Market Breakdown, by Product
11.6.3.4.2 Rest of South and Central America: Opioids Market Breakdown, by Immediate Release Short Acting Opioid
11.6.3.4.3 Rest of South and Central America: Opioids Market Breakdown, by Extended Release Long Acting Opioid
11.6.3.4.4 Rest of South and Central America: Opioids Market Breakdown, by Application
11.6.3.4.5 Rest of South and Central America: Opioids Market Breakdown, by Route Of Administration
11.6.3.4.6 Rest of South and Central America: Opioids Market Breakdown, by Distribution Channel
12. INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in Opioids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Purdue Pharma LP
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Endo International plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Mallinckrodt Plc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Collegium Pharmaceutical Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neuraxpharm Pharmaceuticals SL
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Hikma Pharmaceuticals Plc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Mayne Pharma Group Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Rusan Pharma Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Trevena Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Teva Pharmaceutical Industries Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
14.2 Glossary of Terms
